Prof. Dr. med. Martin Sauer
Vice Chair, Pediatric Hematology and Oncology
Donor immune cells can mediate potent anti-tumor effects after hematopoietic stem cell transplantation. This comes at the expense of potential severe adverse events. BY immunologic and genetic engineering we aim to improve specificity and safety in order to allow the transfer into clinical application.